Clinical Trial Update: A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and effectiveness of ustekinumab in patients with moderate-to-severe Crohn's disease who had prior anti-TNF therapy; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Centocor, Inc. | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-07-27